GROV Quote, Financials, Valuation and Earnings

Kenvue, Inc. has a net margin of -6.77% compared to Grove Collaborative Holdings, Inc.'s net margin of 10.58%. Grove Collaborative Holdings, Inc.'s return on equity of -151.59% beat Kenvue, Inc.'s return on equity of 13.85%.

Grove Collaborative Holdings, Inc. has a consensus price target of $2.00, signalling upside risk potential of 50.38%. On the other hand Kenvue, Inc. has an analysts' consensus of $19.33 which suggests that it could grow by 13.79%. Given that Grove Collaborative Holdings, Inc. has higher upside potential than Kenvue, Inc., analysts believe Grove Collaborative Holdings, Inc. is more attractive than Kenvue, Inc..

Grove Collaborative Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kenvue, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Grove Collaborative Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue, Inc. offers a yield of 4.86% to investors and pays a quarterly dividend of $0.21 per share. Grove Collaborative Holdings, Inc. pays -- of its earnings as a dividend. Kenvue, Inc. pays out 150.5% of its earnings as a dividend.

Grove Collaborative Holdings, Inc. quarterly revenues are $43.7M, which are smaller than Kenvue, Inc. quarterly revenues of $3.8B. Grove Collaborative Holdings, Inc.'s net income of -$3M is lower than Kenvue, Inc.'s net income of $398M. Notably, Grove Collaborative Holdings, Inc.'s price-to-earnings ratio is -- while Kenvue, Inc.'s PE ratio is 22.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings, Inc. is 0.28x versus 2.18x for Kenvue, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health Co. has a net margin of -6.77% compared to Grove Collaborative Holdings, Inc.'s net margin of -15.61%. Grove Collaborative Holdings, Inc.'s return on equity of -151.59% beat The Beauty Health Co.'s return on equity of -19.76%.

Grove Collaborative Holdings, Inc. has a consensus price target of $2.00, signalling upside risk potential of 50.38%. On the other hand The Beauty Health Co. has an analysts' consensus of $1.93 which suggests that it could grow by 22.36%. Given that Grove Collaborative Holdings, Inc. has higher upside potential than The Beauty Health Co., analysts believe Grove Collaborative Holdings, Inc. is more attractive than The Beauty Health Co..

Grove Collaborative Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health Co. has a beta of 1.181, suggesting its more volatile than the S&P 500 by 18.121%.

Grove Collaborative Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Grove Collaborative Holdings, Inc. pays -- of its earnings as a dividend. The Beauty Health Co. pays out -- of its earnings as a dividend.

Grove Collaborative Holdings, Inc. quarterly revenues are $43.7M, which are smaller than The Beauty Health Co. quarterly revenues of $70.7M. Grove Collaborative Holdings, Inc.'s net income of -$3M is higher than The Beauty Health Co.'s net income of -$11M. Notably, Grove Collaborative Holdings, Inc.'s price-to-earnings ratio is -- while The Beauty Health Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings, Inc. is 0.28x versus 0.68x for The Beauty Health Co.. Usually stocks with elevated PS ratios are considered overvalued.

Solesence, Inc. has a net margin of -6.77% compared to Grove Collaborative Holdings, Inc.'s net margin of -7.67%. Grove Collaborative Holdings, Inc.'s return on equity of -151.59% beat Solesence, Inc.'s return on equity of 6.62%.

Grove Collaborative Holdings, Inc. has a consensus price target of $2.00, signalling upside risk potential of 50.38%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Grove Collaborative Holdings, Inc. has higher upside potential than Solesence, Inc., analysts believe Grove Collaborative Holdings, Inc. is more attractive than Solesence, Inc..

Grove Collaborative Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.59%.

Grove Collaborative Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Grove Collaborative Holdings, Inc. pays -- of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend.

Grove Collaborative Holdings, Inc. quarterly revenues are $43.7M, which are larger than Solesence, Inc. quarterly revenues of $14.6M. Grove Collaborative Holdings, Inc.'s net income of -$3M is lower than Solesence, Inc.'s net income of -$1.1M. Notably, Grove Collaborative Holdings, Inc.'s price-to-earnings ratio is -- while Solesence, Inc.'s PE ratio is 155.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings, Inc. is 0.28x versus 2.49x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Waldencast Plc has a net margin of -6.77% compared to Grove Collaborative Holdings, Inc.'s net margin of --. Grove Collaborative Holdings, Inc.'s return on equity of -151.59% beat Waldencast Plc's return on equity of -5.64%.

Grove Collaborative Holdings, Inc. has a consensus price target of $2.00, signalling upside risk potential of 50.38%. On the other hand Waldencast Plc has an analysts' consensus of $3.20 which suggests that it could grow by 31.69%. Given that Grove Collaborative Holdings, Inc. has higher upside potential than Waldencast Plc, analysts believe Grove Collaborative Holdings, Inc. is more attractive than Waldencast Plc.

Grove Collaborative Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Waldencast Plc has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Grove Collaborative Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Grove Collaborative Holdings, Inc. pays -- of its earnings as a dividend. Waldencast Plc pays out -- of its earnings as a dividend.

Grove Collaborative Holdings, Inc. quarterly revenues are $43.7M, which are larger than Waldencast Plc quarterly revenues of --. Grove Collaborative Holdings, Inc.'s net income of -$3M is higher than Waldencast Plc's net income of --. Notably, Grove Collaborative Holdings, Inc.'s price-to-earnings ratio is -- while Waldencast Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings, Inc. is 0.28x versus 0.99x for Waldencast Plc. Usually stocks with elevated PS ratios are considered overvalued.